TrialBritish journal of cancer2003

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.

M B Jameson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.